Welcome to Genafor − Open Services for Medical Research

AREVIR-GenaFor-Meeting 2012


Download Program (PDF)

Donnerstag, 03. Mai 2012

Zeit Vorträge

09:00 - 09:15

Opening Remarks
U. Benjamin Kaup / Stiftung caesar

09:15 - 11:30

Chair: Jens Verheyen
State of ART in HBV /HDV - HOPE
Speakers: Dieter Glebe, Jens Verheyen, Bastian Beggel, Florian Bömmel, Michael Chudy, Valentina Svicher


The HOPE-project HBV polymerase as biomarker of antiviral resistance
Dieter Glebe


Should HIV-1 Gag mutations be included in genotypic drug resistance scores?
Jens Verheyen


Update on geno2pheno[HBV]
Bastian Beggel


Newly-Identified Mutations in HBV RT are associated with failures of selected Anti-HBV treatments and induce alteration or stop codon formation in S Antigen
Valentina Svicher


Development in Hepatitis B Treatment
Slides missing

Florian van Bömmel


Development of an International Reference Preparation for Hepatitis D Virus RNA
Michael Chudy

11:30 - 11:45

Coffee break

11:45 - 13:30

Chair: Rolf Kaiser
State of ART in HCV - PEPSI
Speakers: Volker Lohmann, Thomas von Hahn, Bastian Beggel, Anna Marie Sikorski


HCV: Basic virology, drug targets and -resistance
Volker Lohmann


New challenges in the treatment of chronic hepatitis C virus infection
Thomas von Hahn


Hepatitis C Virus Resistance Testing
Anna Maria Sikorski


Bastian Beggel


COMET: Rapid and reliable HCV subtype predictor
Daniel Struck

13:30 - 14:30


14:30 - 15:30

Chair: Martin Stürmer, Stefan Esser
HIV-1 -2 diagnostics and therapy - state of ART,
HIV-2 Algorithm (HIV-GRADE / CHAIN activities
Speakers: Jean Ruelle, Martin Obermeier


Martin Obermeier


HIV-2: diagnostic tools and antiretroviral therapy
Jean Ruelle

15:30 - 16:30

Chair: Patrick Braun, Tobias Goeser
HIV-1 viral load determination and therapeutic consequences?
HCV viral load determination and therapeutic consequences?
Speakers: Thomas Berg, Christoph Jochum


Low-Level Viremia in HIV
Martin Obermeier


HCV Viral Load Determination and Therapeutic Consequences?
Christoph Jochum

16:30 - 17:00

Coffee break

17:00 - 18:00

Chair: Martin Däumer, Alexander Thielen
NGS (Next Generation Sequencing) and diagnostics
Speakers: Niko Beerenwinkel, Alex Thielen, Francesca Ceccherini-Silberstein


Deep sequencing in clinical virology
Martin Däumer


NGS in clinical Italian practice: impact of minor quasispecies on antiretroviral drug resistance and viral tropism
Daniele Armenia


Freitag, 04. Mai 2012

Zeit Vorträge

09:00 - 09:15

Patient’s view

09:15 - 11:30

Chair: Francesca Incardona, Thomas Lengauer
EuResist present and future: The EuResist database and interpretation system HIV resistance, treatment perspectives and data collection in Russia, Ethiopia, India, Tanzania, South Africa


EuResist Network Present and future
Francesca Incardona


EuResist in Africa: the EDCTP ENNEA project
Maurizio Zazzi


EucoHIV project
Rolf Kaiser


The EuResist engine in Brazil: a preliminary comparative study
Helena Duani, Isadora S. B. Saraiva


History-alignment Models for Bias-aware Prediction of Virological Response to HIV Combination Therapy
Jasmina Bogojeska

11:30 - 11:45

Coffee break

11:45 - 13:30

Chair: Dieter Häussinger, Herbert Pfister
RESINA and RKI-seroconverter study
Speakers: Mark Oette, Alejandro Pironti, Sybille Somogyi, Klaus Jansen, Björn Jensen, Jens Verheyen, Glenn Lawyer


Primary HIV Drug Resistance: The RESINA Study
Mark Oette


A Tool for Predicting the Success of First-Line Antiretroviral Therapies
Alejandro Pironti


Trends in transmission of HIV-1 subtypes and recombinants
Sybille Somogyi


The German HIV-1 Seroconverter cohort study
Klaus Jansen


Should HIV-1 Gag mutations be included in genotypic drug resistance scores?
Jens Verheyen


Phylodynamics of HIV in Germany and Europe
Glenn Lawyer

13:30 - 14:30


14:30 - 15:30

Chair: Nadine Lübke, Hauke Walter
HIV-1 tropism determination and therapy consequences
Speakers: Martin Obermeier, Thomas Klimkait, Chris Verhofstede, Eva Heger, Nico Pfeifer


Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA
Martin Obermeier


Correlation of HIV tropism with immunological response under HAART
Thomas Klimkait


Coreceptor Switch in Treatment Naive Patients
Chris Verhofstede


New methods and new data to improve HIV coreceptor usage prediction
Nico Pfeifer

15:30 - 18:00

Workshop sessions


HIV-resistance and tropism diagnostics and therapy consequences
Stefan Scholten, Alejandro Pironti, Hauke Walter


HIV Tropism
Björn Jensen, Martin Obermeier, Alexander Thielen


HBV resistance and escape
Andreas Erhardt, Ke Zhang, Bastian Beggel


HCV resistance
Nazifia Quirishi, Nico Pfeifer, Saleta Sierra Aragon

18:00 -

Summary of the workshops and closing remarks

Rolf Kaiser

Download Program (PDF)